Australia
· Delayed Price · Currency is AUD Neurizon Therapeutics Statistics
Total Valuation
ASX:NUZ has a market cap or net worth of AUD 68.92 million. The enterprise value is 58.81 million.
| Market Cap | 68.92M |
| Enterprise Value | 58.81M |
Important Dates
The last earnings date was Thursday, April 17, 2025.
| Earnings Date | Apr 17, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ASX:NUZ has 492.31 million shares outstanding. The number of shares has increased by 34.54% in one year.
| Current Share Class | 492.31M |
| Shares Outstanding | 492.31M |
| Shares Change (YoY) | +34.54% |
| Shares Change (QoQ) | +22.82% |
| Owned by Insiders (%) | 21.52% |
| Owned by Institutions (%) | 0.87% |
| Float | 351.37M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 45.47 |
| PB Ratio | 5.79 |
| P/TBV Ratio | 5.79 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -4.04 |
| EV / Sales | 38.80 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.29
| Current Ratio | 4.29 |
| Quick Ratio | 2.81 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -150.50% and return on invested capital (ROIC) is -75.59%.
| Return on Equity (ROE) | -150.50% |
| Return on Assets (ROA) | -60.46% |
| Return on Invested Capital (ROIC) | -75.59% |
| Return on Capital Employed (ROCE) | -98.35% |
| Revenue Per Employee | 378,951 |
| Profits Per Employee | -3.64M |
| Employee Count | 4 |
| Asset Turnover | 0.13 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | 1.24 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 0.12 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 61.35 |
| Average Volume (20 Days) | 262,847 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ASX:NUZ had revenue of AUD 1.52 million and -14.56 million in losses. Loss per share was -0.03.
| Revenue | 1.52M |
| Gross Profit | 1.52M |
| Operating Income | -11.71M |
| Pretax Income | -14.58M |
| Net Income | -14.56M |
| EBITDA | -11.87M |
| EBIT | -11.71M |
| Loss Per Share | -0.03 |
Balance Sheet
The company has 10.11 million in cash and n/a in debt, giving a net cash position of 10.11 million or 0.02 per share.
| Cash & Cash Equivalents | 10.11M |
| Total Debt | n/a |
| Net Cash | 10.11M |
| Net Cash Per Share | 0.02 |
| Equity (Book Value) | 11.91M |
| Book Value Per Share | 0.02 |
| Working Capital | 11.91M |
Cash Flow
| Operating Cash Flow | -10.46M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -772.79% |
| Pretax Margin | -961.63% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ASX:NUZ does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -34.54% |
| Shareholder Yield | -34.54% |
| Earnings Yield | -21.13% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on October 30, 2015. It was a reverse split with a ratio of 0.05.
| Last Split Date | Oct 30, 2015 |
| Split Type | Reverse |
| Split Ratio | 0.05 |
Scores
ASX:NUZ has an Altman Z-Score of 7.55.
| Altman Z-Score | 7.55 |
| Piotroski F-Score | n/a |